Investor Presentation Full Year 2021
118
Investor presentation
Full year 2021
Insulin market size and volume market share in
North America Operations
Total
Insulin market share and market size (DKK billion)
Long-
acting
37%
42%
Fast-
51%
73
acting
58%
Premix
102
27%
Human
15
Novo Nordisk
Competitors
Note: Insulin market numbers do not reflect rebates. See slide 114.
NAO
Market
growth
A Market
share
Insulin volume: market share
60%
12%
198
-3.7%
-1.1%
-2.8%
-1.2%
40%
-3.4%
-0.7%
20%
-14%
+0.1%
0%
Nov
2018
NN market share
-4.8%
-1.6%
Source: IQVIA, Nov 2021, LHS graph - Value, RHS Graph - Volume, MAT, all countries. Share of growth not depicted due to too high numbers; NN: Novo Nordisk
8%
39%
4%
-1%
0%
-3%
-4%
Nov
2021
-Market growth (right axis)
NN growth (right axis)View entire presentation